Enhanced protein expression in mammalian cells using engineered SUMO fusions: Secreted phospholipase A2

SUMOylation, the covalent attachment of SUMO (small ubiquitin‐like modifier), is a eukaryotic post‐translational event that has been demonstrated to play a critical role in several biological processes. When used as an N‐terminal tag or fusion partner, SUMO has been shown to enhance functional protein production significantly by improving folding, solubility, and stability. We have engineered several SUMOs and, through their fusion, developed a system for enhancing the expression and secretion of complex proteins. To demonstrate the fidelity of this fusion technology, secreted phospholipase A2 proteins (sPLA2) were produced using HEK‐293T and CHO‐K1 cells. Five mouse sPLA2 homologs were expressed and secreted in mammalian cell cultures using SUMO or SUMO‐derived, N‐terminal fusion partners. Mean and median increases of 43‐ and 18‐fold, respectively, were obtained using novel SUMO mutants that are resistant to digestion by endogenous deSUMOylases.